Evidence map›Paper›PMID 24278709›Full record

ArticleScientifica2012

A comparison of two classes of methods for estimating false discovery rates in microarray studies.

Emily Hansen, Kathleen F Kerr

Abstract read
In one paragraph

Article in Scientifica, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Emily HansenCancer Research and Biostatistics, Seattle, WA 98101, USA.
Kathleen F Kerr

Funding

XENOBIOTIC BIOTRANSFORMATION AND DISPOSITIONP30ES007033 · NIEHS · UNIVERSITY OF WASHINGTON · PI ALI SHOJAIE · 1995 to 2026
$42.5M
NIEHS NIH HHS P30 ES007033
6 · The paper itself

Abstract

The goal of many microarray studies is to identify genes that are differentially expressed between two classes or populations. Many data analysts choose to estimate the false discovery rate (FDR) associated with the list of genes declared differentially expressed. Estimating an FDR largely reduces to estimating π 1, the proportion of differentially expressed genes among all analyzed genes. Estimating π 1 is usually done through P-values, but computing P-values can be viewed as a nuisance and potentially problematic step. We evaluated methods for estimating π 1 directly from test statistics, circumventing the need to compute P-values. We adapted existing methodology for estimating π 1 from t- and z-statistics so that π 1 could be estimated from other statistics. We compared the quality of these estimates to estimates generated by two established methods for estimating π 1 from P-values. Overall, methods varied widely in bias and variability. The least biased and least variable estimates of π 1, the proportion of differentially expressed genes, were produced by applying the "convest" mixture model method to P-values computed from a pooled permutation null distribution. Estimates computed directly from test statistics rather than P-values did not reliably perform well.

Identifiers

PMID24278709
PMCPMC3820438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.